Clinical Trials Sponsored by Simmons Cancer Center

Total 68131 results

Vanderbilt-Ingram Cancer Center

Terminated

PET/CT Evaluation of Treatment Response in Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies

Advanced Cancer

United States
M.D. Anderson Cancer Center

Terminated

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Leukemia

United States
Fox Chase Cancer Center

Completed

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small... and other conditions

United States
M.D. Anderson Cancer Center

Withdrawn

Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis

Septic Shock
M.D. Anderson Cancer Center

Completed

Objective Assessment of Technical Skills in Cardiothoracic Surgery

Other Surgical Procedures

United States
M.D. Anderson Cancer Center

Withdrawn

Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery

Brain Tumor
M.D. Anderson Cancer Center

Completed

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Lymphoma | Hematologic Diseases | Leukemia | Myeloma

United States
M.D. Anderson Cancer Center

Completed

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

Advanced Cancer

United States
M.D. Anderson Cancer Center

Terminated

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Advanced Cancers

United States
Jonsson Comprehensive Cancer Center

Terminated

Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer

Breast Cancer

United States
Jonsson Comprehensive Cancer Center

Completed

Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Pralatrexate in Advanced Malignancies

Solid Tumors | Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

Lymphoma | Leukemia | Myeloma

United States
M.D. Anderson Cancer Center

Terminated

Hysteroscopic Lymphatic Mapping for Endometrial Cancer

Endometrial Cancer

United States
M.D. Anderson Cancer Center

Terminated

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

Pancreatic Cancer

United States
M.D. Anderson Cancer Center

Terminated

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

Lymphoma
M.D. Anderson Cancer Center

Completed

Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients

Radiation Dermatitis

United States
M.D. Anderson Cancer Center

Completed

Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer

Cervical Cancer

United States
National Cancer Center, Korea

Unknown

A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer (ADDICT)

Gastric Adenocarcinoma

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy

Kidney Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Thermal Signature of Patients Undergoing Radiation Therapy

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials

Advanced Cancer

United States
M.D. Anderson Cancer Center

Terminated

Role of Methadone As Co-Opioid Analgesic

Pain

United States
Vanderbilt-Ingram Cancer Center

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer (68Ga)

Neuroendocrine Carcinoma

United States
National Cancer Center, Korea

Completed

Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients

Early Gastric Cancer

Korea, Republic of
National Cancer Center, Korea

Completed

Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients

Osteosarcoma

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies

Lymphoma

United States
M.D. Anderson Cancer Center

Completed

Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients

Colon Cancer

United States
Case Comprehensive Cancer Center

Completed

Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus

Short Segment Barrett's Esophagus | Long Segment Barrett's Esophagus

United States
Fox Chase Cancer Center

Completed

Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants

Colorectal Cancer | Healthy, no Evidence of Disease

United States
M.D. Anderson Cancer Center

Completed

Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling

Lymphadenopathy

United States
M.D. Anderson Cancer Center

Completed

MATCh Parents' Supplemental Survey

Epidemiology

United States
Case Comprehensive Cancer Center

Withdrawn

Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography

Breast Cancer
M.D. Anderson Cancer Center

Terminated

Multimodal Treatment Strategy for Cancer Cachexia

Cachexia | Advanced Cancer

United States
National Cancer Center, Korea

Completed

Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer

Breast Cancer

Korea, Republic of
Jonsson Comprehensive Cancer Center

Completed

Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Completed

Smoking Status and Body Image in Oral Cancer Patients

Oral Cavity Cancer

United States
M.D. Anderson Cancer Center

Completed

Lapatinib With Sirolimus or Metformin

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets

Prostate Cancer

United States
National Cancer Center, Korea

Unknown

MAC Bipsectral Index Below 50 for Chronic Opioid User

Anesthesia

Korea, Republic of
National Cancer Center, Korea

Completed

A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node Dissection

Breast Cancer

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Elizabeth Registry for Low Grade Ovarian Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center

Completed

Docetaxel and Sirolimus in Patients With Advanced Malignancies

Advanced Cancer

United States
Case Comprehensive Cancer Center

Terminated

A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer

Any Cancer Diagnosis

United States
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Cetuximab

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status

Advanced Cancers

United States
National Cancer Center, Korea

Unknown

Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy

Rectal Cancer

Korea, Republic of

3

Subscribe